BioAMPs International

BioAMPs International is a biotechnology company dedicated to addressing the global crisis of antimicrobial resistance (AMR) through the development of novel antimicrobial peptides (AMPs). The company utilizes its proprietary BioAMPs platform to design and optimize synthetic peptides that target multi-drug resistant (MDR) pathogens with high specificity and low toxicity. Their research focuses on treating life-threatening conditions such as sepsis and complicated skin infections caused by ESKAPE pathogens. By leveraging advanced peptide engineering and computational design, BioAMPs International aims to provide next-generation therapeutic alternatives to traditional antibiotics.